Authors: O'Neill, MJ Murray, TK McCarty, DR Hicks, CA Dell, CP Patrick, KE Ward, MA Osborne, DJ Wiernicki, TR Roman, CR Lodge, D Fleisch, JH Singh, J

Citation: Mj. O'Neill et al., ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia, BRAIN RES, 871(2), 2000, pp. 234-244

Authors: Snyder, DW Bach, NJ Dillard, RD Draheim, SE Carlson, DG Fox, N Roehm, NW Armstrong, CT Chang, CH Hartley, LW Johnson, LM Roman, CR Smith, AC Song, M Fleisch, JH

Citation: Dw. Snyder et al., Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetate, a potent and selective secretory phospholipase A(2) inhibitor: A new class of anti-inflammatory drugs, SPI, J PHARM EXP, 288(3), 1999, pp. 1117-1124

Authors: Jackson, WT Froelich, LL Boyd, RJ Schrementi, JP Saussy, DL Schultz, RM Sawyer, JS Sofia, MJ Herron, DK Goodson, T Snyder, DW Pechous, PA Spaethe, SM Roman, CR Fleisch, JH

Citation: Wt. Jackson et al., Pharmacologic actions of the second-generation leukotriene B-4 receptor antagonist LY293111: In vitro studies, J PHARM EXP, 288(1), 1999, pp. 286-294